Is NADH effective in the treatment of Parkinson's disease? (Q30472795)

21 June 2017

1 reference

title

Is NADH effective in the treatment of Parkinson's disease? (English)

1 reference

21 June 2017

1 reference

Swerdlow RH

1

1 reference

21 June 2017

publication date

1 October 1998

1 reference

21 June 2017

1 reference

21 June 2017

volume

13

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

263-268

1 reference

Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH)

21 June 2017

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

1 reference

12 December 2020

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

12 December 2020

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

1 reference

12 December 2020

The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients.

1 reference

12 December 2020

1 reference

12 December 2020

The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase.

1 reference

12 December 2020

Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers

1 reference

12 December 2020

Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.

1 reference

12 December 2020

Improvement of disability and akinesia of patients with Parkinson's disease by intravenous iron substitution

1 reference

12 December 2020

Treatment of Parkinson's disease with NADH

1 reference

12 December 2020

Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea

1 reference

12 December 2020

Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism

1 reference

12 December 2020

Biopterin in Parkinson's disease

1 reference

12 December 2020

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

12 December 2020

Oxyferriscorbone elevates the total iron content of blood but not brain

1 reference

12 December 2020

Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease

1 reference

12 December 2020

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys

1 reference

12 December 2020

The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients

1 reference

12 December 2020

Biopterin in human brain and urine from controls and parkinsonian patients: Application of a new radioimmunoassay

1 reference

12 December 2020

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

12 December 2020

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Iron, a new aid in the treatment of Parkinson patients

1 reference

12 December 2020

Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies

1 reference

12 December 2020

Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).

1 reference

12 December 2020

10.2165/00002512-199813040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1035160297

0 references

1 reference